Showing results (761-770 of 6,300) with videos related to
Sort By:
Pageof 630
Diabetes, Obesity & Metabolism|February 12, 2016
Comparison of alogliptin and glipizide for composite endpoint of glycated haemoglobin reduction, no hypoglycaemia and no weight gain in type 2 diabetes mellitusS Del Prato, P Fleck, C Wilson, et al.Diabetes, Obesity & Metabolism|March 4, 2016
Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 analogue, in Latino/Hispanic patients with type 2 diabetes: post hoc analysis of data from four phase III trialsJ A Davidson, D D Ørsted, C CamposDiabetes, Obesity & Metabolism|September 3, 2015
Coupling circadian rhythms of metabolism and chromatin remodellingS Masri, R Orozco-Solis, L Aguilar-Arnal, et al.Diabetes, Obesity & Metabolism|September 3, 2015
Circadian rhythm-related genes: implication in autoimmunity and type 1 diabetesB Lebailly, C Boitard, U C RognerDiabetes, Obesity & Metabolism|August 1, 2015
Pancreatic β-cell imaging in humans: fiction or option?D Laurent, L Vinet, S Lamprianou, et al.Diabetes, Obesity & Metabolism|December 11, 2014
Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetesH Thabit, D Elleri, L Leelarathna, et al.Diabetes, Obesity & Metabolism|January 21, 2015
Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)M A Bethel, J B Green, J Milton, et al.Diabetes, Obesity & Metabolism|August 27, 2014
Glucagon-like peptide 1 receptor agonists and cardiovascular risk in type 2 diabetes: a clinical perspectiveM FisherDiabetes, Obesity & Metabolism|November 27, 2014
Low within- and between-day variability in exposure to new insulin glargine 300 U/mlR H A Becker, I Nowotny, L Teichert, et al.Pageof 630